Tag: Shore Capital Partners
Why is Walgreens shopping its home infusion biz?
September 26, 2014Theresa Flaherty, Managing Editor
DEERFIELD, Ill. - News that Walgreens is mulling the sale of a controlling stake in its home infusion business came as no surprise to analysts.“I think Walgreens recognizes that this is a core asset and would probably be valued quite substantially by a third party,” said Justin Ishbia, founder and managing partner of Shore Capital Partners. “There will be a lot of interest from a lot of people.”The news of the potential sale follows CVS Caremark's acquisition of Coram from...